NCT03910296View on ClinicalTrials.gov

Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

February 20, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

July 30, 2021

Conditions
Cancer
Interventions
BEHAVIORAL

Acceptance & Commitment Therapy

ACT is a unique, third-wave therapy that uses metaphors and experiential exercises to encourage contact with previously avoided thoughts, feelings, and behaviors.

Trial Locations (1)

02115

Dana Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT03910296 - Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain | Biotech Hunter | Biotech Hunter